Celularity Inc — Director's Dealing 2023

Oct 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2023-08-31

Reporting Person: Ling Geoffrey M.D. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-31	Stock Option Grant (Right to Buy)	$0.324	A	1250000	Acquired	2033-08-31	Class A Common Stock (1250000)	Direct

Footnotes

F1: The option was granted pursuant to the Issuer's 2021 Equity Incentive Plan. The shares underlying such option will vest in three successive equal annual installments measured from the grant date, subject to the Reporting Person's continuous service with the Issuer through each such date.